ONC02

Evolving Treatment Paradigms in HR-Positive, HER2-Negative Breast Cancer: Integrating the Latest Evidence Into Clinical Practice

Date

September 24, 2022

Explore related products in the following collection:

Oncology Congress

Speakers

Chris Prakash, MD

Medical Director, Texas Oncology - Paris

Harold J. Burstein, MD, PhD

Medical Oncologist, Dana-Farber Cancer Institute

Related Products

Thumbnail for Updates in the Diagnosis and Management of Chronic Lymphocytic Leukemia: Strategies for Addressing Disparities in Patient Care and Outcomes

Updates in the Diagnosis and Management of Chronic Lymphocytic Leukemia: Strategies for Addressing Disparities in Patient Care and Outcomes

Thumbnail for Integrating the Latest Evidence on Immune Checkpoint Inhibitors Into the Management of Advanced Non-Small Cell Lung Cancer

Integrating the Latest Evidence on Immune Checkpoint Inhibitors Into the Management of Advanced Non-Small Cell Lung Cancer

Thumbnail for Mitigating Disparities in Prostate Cancer Care: Strategies to Promote Equitable Care Across the Continuum

Mitigating Disparities in Prostate Cancer Care: Strategies to Promote Equitable Care Across the Continuum

Thumbnail for Overcoming Barriers to Equitable Care in Hepatocellular Carcinoma: Integrating New Evidence Into Clinical Practice

Overcoming Barriers to Equitable Care in Hepatocellular Carcinoma: Integrating New Evidence Into Clinical Practice